Pancreatic enzyme replacement is a core part of managing dogs with diagnosed exocrine pancreatic insufficiency (EPI). Controlled canine trials compare different pancreatic-enzyme formulations within that disease context.

That evidence does not show that healthy dogs, or dogs with vague digestive complaints, benefit from routine over-the-counter digestive-enzyme blends.

Key takeaways

Why EPI is different

Exocrine pancreatic insufficiency is not simply “poor digestion.” It is a disease state in which the pancreas does not provide sufficient digestive enzymes to the intestine.

That creates a specific replacement problem: enzymes that are missing or inadequate must be supplied with food.

This is fundamentally different from adding enzymes to the diet of a dog whose pancreatic function is normal.

What did controlled canine trials examine?

Thirty-eight dogs with naturally occurring EPI

A multicenter blinded randomized controlled trial included 38 client-owned dogs with naturally occurring EPI. Dogs received either an enteric-coated pancreatic-enzyme preparation or an otherwise identical preparation without enteric coating for 56 days.

The study found no significant advantage of enteric coating for the main clinical outcomes assessed. The trial is valuable because it tests how pancreatic enzyme replacement should be formulated in dogs that actually have EPI.

It does not test whether pancreatic enzymes benefit healthy dogs.

Eleven-dog randomized crossover trial

A later randomized blinded controlled crossover trial enrolled 11 dogs with naturally occurring EPI. It compared a novel micro-encapsulated enteric-coated enzyme supplement with a commercially available uncoated pancreatic-enzyme product.

The primary fecal-fat outcome did not show a significant difference between formulations (P = .15). Again, the question was formulation performance within EPI treatment—not whether enzyme supplementation was useful for general wellness.

What these trials prove—and what they do not

The trials support the clinical relevance of pancreatic enzyme replacement as an EPI management strategy and show that formulation details can matter enough to study directly.

They do not establish that:

pancreatic enzyme replacement in EPI ≠ generic digestive-enzyme wellness evidence

Pancreatic extracts are not the same as generic enzyme blends

A retail digestive supplement may contain proteases, lipases, amylases, plant enzymes, microbial enzymes, or mixtures of several ingredients.

A pancreatic-enzyme replacement trial in dogs with EPI cannot automatically support those formulations. Exact enzyme source, activity units, stability, dosing context, and disease state all differ.

Why disease-treatment evidence is easy to misuse

EPI creates a strong treatment effect because there is a defined physiological deficit. In marketing, that can be turned into a much broader claim: “enzymes help digestion, therefore all dogs may benefit.”

That is an evidence upgrade the research does not justify.

What a shopper should ask

When a dog digestive supplement cites enzyme science, ask:

  1. Was the evidence in dogs?
  2. Were the dogs diagnosed with EPI?
  3. Was the tested intervention a pancreatic extract or a different enzyme blend?
  4. Was the exact commercial formula tested?
  5. Was the outcome clinical, or only a laboratory digestion measure?

When veterinary evaluation matters

Persistent weight loss, chronic diarrhea, poor body condition, or other signs of maldigestion require veterinary assessment. This article is not a diagnostic guide and should not be used to decide whether a dog has EPI.

Dog Supplement Facts evidence status

VERIFIED_SUPPORTIVE for pancreatic enzyme replacement in diagnosed canine EPI.

INSUFFICIENT for routine digestive-enzyme supplementation in dogs without diagnosed pancreatic insufficiency.

In our comparison: products that list pancreatic enzymes (diagnosed EPI)

11 of the 245 dog digestive products we compared list pancreatic enzymes (diagnosed EPI) (4%). None of them is among the 20 most popular products, and their median popularity rank is #144 of 209 ranked products. Our ingredient-level evidence rating for pancreatic enzymes (diagnosed EPI): supportive.

Product-level ratings, which look at the whole formula: 11 supportive.

Most popular of these:

  1. #68Probiotics for Dogs - 170 Dog Probiotics Chews - Digestive Enzymes Support — Supportive
  2. #78Probiotics for Dogs - 250 Dog Probiotics Chews - Digestive Enzymes Support — Supportive
  3. #100Super Poop Probiotics for Dogs Chews - Dog Stool Softener - Made in USA — Supportive
  4. #141Enzymes for Cats & Dogs : Enzyme Miracle® (100 Servings) : for Digestive Stress, Pancreatic Concerns, and… — Supportive
  5. #144Amazing Probiotics for Dogs Eliminates Diarrhea and Gas with Hip Joint Pain Relief, 120 Chews — Supportive

Popularity is a relative rank within our comparison (purchases, review volume and star rating), not Amazon's Best Sellers Rank and not a measure of effectiveness. Listing data collected September 2026.

Frequently asked questions

What is exocrine pancreatic insufficiency (EPI) in dogs?

A disease in which the pancreas does not supply enough digestive enzymes to the intestine. It needs a veterinary diagnosis; signs such as weight loss, chronic diarrhea or poor body condition should be checked by a vet.

Do pancreatic enzymes work for dogs with EPI?

Pancreatic enzyme replacement given with food is a core part of managing diagnosed EPI. Controlled dog trials have compared different preparations, such as coated versus uncoated, within that disease.

Can I give pancreatic enzymes to a healthy dog?

There is no evidence that healthy dogs benefit. Evidence from EPI treatment does not apply to dogs with normal pancreatic function, and enzyme supplements are not a substitute for diagnosing digestive problems.

References

  1. Mansfield CS, James FE, Steiner JM, et al. A blinded randomised controlled trial to determine the effect of enteric coating on enzyme treatment for canine exocrine pancreatic insufficiency. BMC Veterinary Research. 2012;8:127. PMID 22839732. doi:10.1186/1746-6148-8-127.
  2. Parambeth JC, Suchodolski JS, Steiner JM, et al. Randomized controlled crossover trial of an enteric-coated micro-pelleted pancreatic enzyme supplement in dogs with exocrine pancreatic insufficiency. Journal of Veterinary Internal Medicine. 2018;32(5):1591–1599. PMID 30221800. doi:10.1111/jvim.15235.